
Chronic Constriction Injury (CCI) Model
Chronic Constriction Injury (CCI)
Chronic Constriction Injury is a discrete peripheral nerve injury model, originally described by Bennett and Xie (1988), that closely relates to post-traumatic or postsurgical neuropathic pain in patients. Loose ligation of the sciatic nerve induces local inflammation and intraneural constriction, producing a unilateral peripheral mononeuropathy.
This results in robust mechanical and cold allodynia, tactile allodynia, and thermal hyperalgesia, with the pain phenotype persisting for at least 84 days. Analgesic potency of test compounds is typically assessed after 14 days post-surgery in rats and after 21 days post-surgery in mice, once the phenotype is fully established.
The model demonstrates pharmacological validity through sensitivity to clinically established treatments — including pregabalin, duloxetine, naproxen, or morphine — establishing it as a robust and widely used preclinical model for evaluating analgesic candidates targeting peripheral neuropathic pain.

Paw withdrawal thresholds were assessed using von Frey filaments. After CCI lowered thresholds, pregabalin (30 mg/kg) increased them compared with vehicle at 0.5 and 3 hours on days 22 and 24.